Price $2.06 |
Market Cap
194.9M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
3.77
|
P/S
0.45
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
53.1
|
Op. Cash Flow
8.4K
|
FCF
0.0
|
|
Op. Margin
0.10%
|
Net Margin
-3.00%
|
ROE
-23.90%
|
ROI
4.30%
|
|
ROA
-2.70%
|
EPS Growth
-380.90%
|
Current Ratio
1.8
|
Debt/Equity
247.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Capricor Therapeutics Inc (CAPR) | $5.93 | - | - | 109.2M | Strong Buy |
| Novo Integrated Sciences Inc (NVOS) | $1.12 | - | - | 57.1M | Strong Buy |
| Clearside Biomedical Inc (CLSD) | $1.08 | - | - | 99.2M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $2.60 | - | - | 152.2M | Strong Buy |
| KORU Medical Systems Inc (KRMD) | $2.27 | - | - | 104.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
